Skip to content

Virtual Reality Avatar Therapy for People Hearing Voices

Virtual Reality Avatar Therapy for People Hearing Voices

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04099940
Enrollment
100
Registered
2019-09-23
Start date
2021-07-01
Completion date
2025-12-31
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Voices When No One is Talking (Symptom), Psychosis, Schizo Affective Disorder, Schizophrenia

Keywords

Hearing Voices, Virtual Reality Avatar Therapy, Cognitive Behavioural Therapy

Brief summary

Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to influence and control the hallucinatory experience itself. In recent years virtual reality has become a treatment option. In the so-called AVATAR Therapy, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent. Avatar Therapy involves similar processes to learning and cognitive restructuring, comparable to other psychotherapeutic interventions. The investigators plan to conduct an interventional study using a cross-over design, to compare the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group therapy aimed to improve social competence.

Interventions

BEHAVIORALVirtual Reality Avatar Therapy (VRAT)

The Virtual Reality Avatar Therapy (VRAT) is a Cognitive Behavioral Intervention, delivered through Virtual Reality.

The Assertiveness Training Program (ATP) is a Cognitive Behavioral Intervention, delivered as group therapy.

Sponsors

Psychiatric University Hospital, Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

The investigators plan to conduct a single-blind, randomised, controlled trial in a cross-over design to assess the feasibility and efficacy of VRAT in patients with acoustic hallucinations, independent of the main diagnosis.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Consistent acoustic hallucinations, with the presence of voices for at least two months. * Participants are competent to give informed consent, as determined by the referring physician or psychiatrist. * German language proficiency as a native speaker or level B1 Common European Framework of Reference for Languages (CEFRL)

Exclusion criteria

* Current neurological disorder. * Current substance use or withdrawal. * Concomitant group psychotherapeutic intervention.

Design outcomes

Primary

MeasureTime frameDescription
Psychopathological AssessmentChange: Baseline, 3, 6 weeks, 6 and 12 months]Symptom Questionnaire

Secondary

MeasureTime frameDescription
Psychotic SymptomsChange: Baseline, 3, 6 weeks, 6 and 12 months]Symptom Questionnaire
Insecurity- Self-confidenceChange: Baseline, 3, 6 weeks, 6 and 12 months]Symptom Questionnaire

Countries

Switzerland

Contacts

Primary ContactStephan T. Egger, MD
stephan.egger@puk.zh.ch+41523049340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026